Vascular dysfunction—The disregarded partner of Alzheimer's disease

[1]  Keith A. Johnson,et al.  Interactive Associations of Vascular Risk and &bgr;-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study , 2018, JAMA neurology.

[2]  Michael Weiner,et al.  White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease , 2018, PloS one.

[3]  Prashanthi Vemuri,et al.  Resistance vs resilience to Alzheimer disease , 2018, Neurology.

[4]  D. Knopman,et al.  Arterial stiffness and dementia pathology , 2018, Neurology.

[5]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[6]  A. Avolio,et al.  Cerebral Haemodynamics: Effects of Systemic Arterial Pulsatile Function and Hypertension , 2018, Current Hypertension Reports.

[7]  V. Hachinski,et al.  Concomitant vascular and neurodegenerative pathologies double the risk of dementia , 2018, Alzheimer's & Dementia.

[8]  Berislav V. Zlokovic,et al.  Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.

[9]  Jenq-Neng Hwang,et al.  Development of a quantitative intracranial vascular features extraction tool on 3D MRA using semiautomated open‐curve active contour vessel tracing , 2017, Magnetic resonance in medicine.

[10]  A. Gjedde,et al.  Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment , 2017, Scientific Reports.

[11]  B. Zlokovic,et al.  Alzheimer’s disease: A matter of blood–brain barrier dysfunction? , 2017, The Journal of experimental medicine.

[12]  W. M. van der Flier,et al.  Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging , 2017, Alzheimer's & dementia.

[13]  Prashanthi Vemuri,et al.  Age, vascular health, and Alzheimer disease biomarkers in an elderly sample , 2017, Annals of neurology.

[14]  Arne Møller,et al.  Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease , 2017, Alzheimer's & Dementia.

[15]  M. Kilbourn.  Small Molecule PET Tracers for Transporter Imaging. , 2017, Seminars in nuclear medicine.

[16]  M. van Buchem,et al.  Subtle blood‐brain barrier leakage rate and spatial extent: Considerations for dynamic contrast‐enhanced MRI , 2017, Medical physics.

[17]  D. Nation,et al.  Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia , 2017, Brain : a journal of neurology.

[18]  Wei Zhang,et al.  The value of whole-brain CT perfusion imaging and CT angiography using a 320-slice CT scanner in the diagnosis of MCI and AD patients , 2017, European Radiology.

[19]  J. Wardlaw,et al.  Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study , 2017, Alzheimer's & Dementia.

[20]  A. Rahmim,et al.  Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition , 2017, JAMA.

[21]  M. Haaparanta-Solin,et al.  HPLC and TLC methods for analysis of [18F]FDG and its metabolites from biological samples. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[22]  Miranka Wirth,et al.  Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  Eleni Sakka,et al.  Integrity of normal-appearing white matter: Influence of age, visible lesion burden and hypertension in patients with small-vessel disease , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  Sterling C. Johnson,et al.  Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease , 2017, Alzheimer's & dementia.

[25]  Marta Vidorreta,et al.  Reduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI. , 2017, Journal of Alzheimer's disease : JAD.

[26]  James Duffin,et al.  Cerebrovascular reactivity and white matter integrity , 2016, Neurology.

[27]  F. de Leeuw,et al.  A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms , 2016, Annals of neurology.

[28]  Sterling C. Johnson,et al.  4D flow MRI for intracranial hemodynamics assessment in Alzheimer’s disease , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  Walter H. Backes,et al.  Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging , 2016, Neurobiology of Aging.

[30]  I. Zerr,et al.  Cerebral microbleeds in early Alzheimer’s disease , 2016, Journal of Neurology.

[31]  Norbert Schuff,et al.  Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.

[32]  David A. Bennett,et al.  Relation of Cerebral Vessel Disease to Alzheimer’s Disease Dementia and Cognitive Function in Older Persons: A Cross-sectional Study , 2016, The Lancet Neurology.

[33]  Nick C Fox,et al.  White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network , 2016, Annals of neurology.

[34]  Walter H Backes,et al.  Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease. , 2016, Radiology.

[35]  Arthur W. Toga,et al.  Brain imaging of neurovascular dysfunction in Alzheimer’s disease , 2016, Acta Neuropathologica.

[36]  S. Leh,et al.  Arterial spin labeling imaging reveals widespread and Aβ-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  Xin Lou,et al.  Reduced perfusion in normal‐appearing white matter in mild to moderate hypertension as revealed by 3D pseudocontinuous arterial spin labeling , 2016, Journal of magnetic resonance imaging : JMRI.

[38]  V. Hachinski.  Correction. World Stroke Organization. Stroke and potentially preventable dementias proclamation: updated World Stroke Day proclamation. , 2016, Stroke.

[39]  L. Wahlund,et al.  Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field. , 2016, Biomarkers in medicine.

[40]  V. Hachinski,et al.  Declining Incidence of Stroke and Dementia: Coincidence or Prevention Opportunity? , 2015, JAMA neurology.

[41]  Zhen Zhao,et al.  Establishment and Dysfunction of the Blood-Brain Barrier , 2015, Cell.

[42]  V. Hachinski.  Stroke and Potentially Preventable Dementias Proclamation: Updated World Stroke Day Proclamation. , 2015, Stroke.

[43]  B. Zlokovic,et al.  Shedding of soluble platelet-derived growth factor receptor-β from human brain pericytes , 2015, Neuroscience Letters.

[44]  Paul M. Matthews,et al.  Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele , 2015, Alzheimer's & Dementia.

[45]  J. Schneider,et al.  Vascular contributions to cognitive impairment and dementia including Alzheimer's disease , 2015, Alzheimer's & Dementia.

[46]  B. Zlokovic,et al.  Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[47]  D. Salmon,et al.  Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease , 2015, Alzheimer's & Dementia.

[48]  Jesse D. Sengillo,et al.  GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration , 2015, Nature Neuroscience.

[49]  L. Wahlund,et al.  Cerebral Microbleeds: Different Prevalence, Topography, and Risk Factors Depending on Dementia Diagnosis—The Karolinska Imaging Dementia Study , 2015, American Journal of Neuroradiology.

[50]  Farzaneh A. Sorond,et al.  Apolipoprotein E, Carbon Dioxide Vasoreactivity, and Cognition in Older Adults: Effect of Hypertension , 2015, Journal of the American Geriatrics Society.

[51]  Sven Haller,et al.  Arterial spin labeling may contribute to the prediction of cognitive deterioration in healthy elderly individuals. , 2015, Radiology.

[52]  Arthur W. Toga,et al.  Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.

[53]  D J Mikulis,et al.  Cerebrovascular Reactivity Mapping: An Evolving Standard for Clinical Functional Imaging , 2015, American Journal of Neuroradiology.

[54]  D. Werring,et al.  White Matter Changes in Dementia: Role of Impaired Drainage of Interstitial Fluid , 2015, Brain pathology.

[55]  C. Torborg,et al.  Recommendations of the Alzheimer's Disease–Related Dementias Conference , 2014, Neurology.

[56]  L. Kuller,et al.  Arterial stiffness and β-amyloid progression in nondemented elderly adults. , 2014, JAMA neurology.

[57]  Alexander Leemans,et al.  Multiple microbleeds are related to cerebral network disruptions in patients with early Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[58]  C. Iadecola,et al.  The Pathobiology of Vascular Dementia , 2013, Neuron.

[59]  J. Trojanowski,et al.  Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. , 2013, Brain : a journal of neurology.

[60]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[61]  M. Dichgans,et al.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging , 2013, The Lancet Neurology.

[62]  G. Alexander,et al.  Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. , 2013, JAMA neurology.

[63]  S. Black,et al.  Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT , 2013, European journal of neurology.

[64]  S. Vallabhajosula,et al.  Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents , 2013, Neurobiology of Aging.

[65]  W. M. van der Flier,et al.  Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia , 2013, Neurology.

[66]  D. Salmon,et al.  Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[67]  Nick C Fox,et al.  EFNS task force: the use of neuroimaging in the diagnosis of dementia , 2012, European journal of neurology.

[68]  A. Fleisher,et al.  Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons , 2012, Neurobiology of Aging.

[69]  Timo Grimmer,et al.  Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRI , 2012, European Archives of Psychiatry and Clinical Neuroscience.

[70]  Cindee M. Madison,et al.  Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI , 2011, Neurobiology of Aging.

[71]  Chengjie Xiong,et al.  Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis , 2011, PloS one.

[72]  Michèle Allard,et al.  Brain fuel metabolism, aging, and Alzheimer's disease. , 2011, Nutrition (Burbank, Los Angeles County, Calif.).

[73]  J. Morris,et al.  Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.

[74]  Cindee M. Madison,et al.  Comparing predictors of conversion and decline in mild cognitive impairment , 2010, Neurology.

[75]  S. Resnick,et al.  APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. , 2010, Archives of neurology.

[76]  Marc Dhenain,et al.  Detection of vascular alterations by in vivo magnetic resonance angiography and histology in APP/PS1 mouse model of Alzheimer’s disease , 2010, Magnetic Resonance Materials in Physics, Biology and Medicine.

[77]  E. Rostrup,et al.  Measurement of brain perfusion, blood volume, and blood‐brain barrier permeability, using dynamic contrast‐enhanced T1‐weighted MRI at 3 tesla , 2009, Magnetic resonance in medicine.

[78]  Maximilian Reiser,et al.  Quantification of cerebral blood flow, cerebral blood volume, and blood–brain‐barrier leakage with DCE‐MRI , 2009, Magnetic resonance in medicine.

[79]  James T Becker,et al.  Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. , 2009, Radiology.

[80]  A. Hofman,et al.  Prevalence and risk factors of cerebral microbleeds , 2008, Neurology.

[81]  E. Reiman,et al.  Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.

[82]  Uwe Haberkorn,et al.  Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease , 2007, Psychiatry Research: Neuroimaging.

[83]  H. Matsuda,et al.  Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer’s disease , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[84]  M. D. de Leon,et al.  Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[85]  Takashi Asada,et al.  Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography , 2006, Nuclear medicine communications.

[86]  Hiroshi Matsuda,et al.  The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT , 2005, NeuroImage.

[87]  A. Hofman,et al.  Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study , 2005, Annals of neurology.

[88]  J. de Pina-Cabral,et al.  World , 2004, Science.

[89]  D. Davies,et al.  Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease , 2004, Virchows Archiv.

[90]  H. Parkes,et al.  Tissue‐specific differences in 2‐fluoro‐2‐deoxyglucose metabolism beyond FDG‐6‐P: a 19F NMR spectroscopy study in the rat , 2003, NMR in biomedicine.

[91]  Takashi Asada,et al.  Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[92]  George A. Carlson,et al.  Alterations in Cerebral Blood Flow and Glucose Utilization in Mice Overexpressing the Amyloid Precursor Protein , 2002, Neurobiology of Disease.

[93]  T. Ohnishi,et al.  Longitudinal Evaluation of Early Alzheimer's Disease Using Brain Perfusion Spect the Recruitment Was For , 2000 .

[94]  J. Detre,et al.  Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.

[95]  T. Arendt,et al.  Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease , 1999, Journal of Neural Transmission.

[96]  G. Shah,et al.  GLUT-1 Expression in the Cerebra of Patients with Alzheimer’s Disease , 1997, Neurobiology of Aging.

[97]  D E Kuhl,et al.  Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[98]  W. Honer,et al.  Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease , 1994, Annals of neurology.

[99]  W. Jagust,et al.  Diminished Glucose Transport in Alzheimer's Disease: Dynamic PET Studies , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[100]  L. Sokoloff,et al.  Measurement of local cerebral glucose utilization and its relation to local functional activity in the brain. , 1991, Advances in experimental medicine and biology.

[101]  O. H. Lowry,et al.  Use of nonradioactive 2-deoxyglucose to study compartmentation of brain glucose metabolism and rapid regional changes in rate. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[102]  R N Kalaria,et al.  Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease , 1989, Journal of neurochemistry.

[103]  H. Fukuyama,et al.  Glucose metabolism and rate constants in Alzheimer's disease examined with dynamic positron emission tomography scan , 1989, Acta neurologica Scandinavica.

[104]  R. Veech,et al.  Metabolic Fluxes Between [14C]2‐Deoxy‐D‐Glucose and [14C]2‐Deoxy‐D‐Glucose‐6‐Phosphate in Brain In Vivo , 1985, Journal of neurochemistry.

[105]  W. Meier-Ruge,et al.  Glycolytic enzymes from human autoptic brain cortex: Normal aged and demented cases , 1980, Mechanisms of Ageing and Development.

[106]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[107]  A. Sols,et al.  Substrate specificity of brain hexokinase. , 1954, The Journal of biological chemistry.

[108]  C. de Duve,et al.  [The hexosephosphatase system; partition of activity of glucose-6-phosphatase in the tissues]. , 1950, Bulletin de la Societe de chimie biologique.